Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Current nucleic acid amplification methods to detect Mycobacterium tuberculosis are complex, labor-intensive, and technically challenging. We developed and performed the first analysis of the Cepheid Gene Xpert System's MTB/RIF assay, an integrated hands-free sputum-processing and real-time PCR system with rapid on-demand, near-patient technology, to simultaneously detect M. tuberculosis and rifampin resistance. Analytic tests of M. tuberculosis DNA demonstrated a limit of detection (LOD) of 4.5 genomes per reaction. Studies using sputum spiked with known numbers of M. tuberculosis CFU predicted a clinical LOD of 131 CFU/ml. Killing studies showed that the assay's buffer decreased M. tuberculosis viability by at least 8 logs, substantially reducing biohazards. Tests of 23 different commonly occurring rifampin resistance mutations demonstrated that all 23 (100%) would be identified as rifampin resistant. An analysis of 20 nontuberculosis mycobacteria species confirmed high assay specificity. A small clinical validation study of 107 clinical sputum samples from suspected tuberculosis cases in Vietnam detected 29/29 (100%) smear-positive culture-positive cases and 33/39 (84.6%) or 38/53 (71.7%) smear-negative culture-positive cases, as determined by growth on solid medium or on both solid and liquid media, respectively. M. tuberculosis was not detected in 25/25 (100%) of the culture-negative samples. A study of 64 smear-positive culture-positive sputa from retreatment tuberculosis cases in Uganda detected 63/64 (98.4%) culture-positive cases and 9/9 (100%) cases of rifampin resistance. Rifampin resistance was excluded in 54/55 (98.2%) susceptible cases. Specificity rose to 100% after correcting for a conventional susceptibility test error. In conclusion, this highly sensitive and simple-to-use system can detect M. tuberculosis directly from sputum in less than 2 h.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have shown that Xpert does not cross‐react with other mycobacterial species (Blakemore 2010; Helb 2010).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Helb 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This represents a substantial reduction in diagnostic delay, thereby permitting real-time decision making and planning of treatment (5).”
From Xpert MTB/RIF for Rapid Diagnosis of Tuberculous Lymphadenitis from Fine-Needle-Aspiration Biopsy Specimens (2011) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies reported 98–100% agreement in detection of rifampicin resistance strains using the Xpert test and phenotypic drug susceptibility test [13,14,18,26].”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Such cases (Xpert-positive but culture-negative) are likely to be true TB positives as corroborated by the high specificity [14,18] and by the fact that the procedure is less prone to contamination due to the closed reaction chamber (real-time PCR technology) of Xpert.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“In agreement with other studies [9,18,22], Xpert has a higher sensitivity than smear microscopy.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Two-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
Probable Inference, the Law of Succession, and Statistical Inference
Wilson, E. B. (1927) · Journal of the American Statistical Association · doi:10.1080/01621459.1927.10502953 · Cited by 4,476
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
The association for the advancement of medical instrumentation
(1974) · Ultrasound in Medicine & Biology · doi:10.1016/0301-5629(74)90035-0 · Cited by 1,031
Anti-tuberculosis drug resistance in the world
Wilkinson, D. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90766-0 · Cited by 700
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525 · cited 1×
“tuberculosis detection (15), this assay was too complex and too prone to operator errors, sample cross-contamination, and biohazards for rapid near-patient use.”
BackgroundEspinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507 · cited 3×
“Truly rapid results for drug susceptibility tests are particularly important in the management of drug-resistant tuberculosis (13).”
BackgroundMicroscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
Moore, D. A. J., Evans, C. A. W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Piñedo, Y., Saravia, J. C., Salazar, C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055524 · Cited by 468
Cited by
Items 201–300 of 940
Rice, J. P., Seifert, M., Moser, K., & Rodwell, T. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186139 · Cited by 53
Pavankumar, A. R., Engström, A., Liu, J., Herthnek, D., & Nilsson, M. F. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04312 · Cited by 49
Rahman, S. M. M., Maliha, U. T., Ahmed, S., Kabir, S., Khatun, R., Shah, J. A., & Banu, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203063 · Cited by 49
Kumari, S. L., Reddy, D., Kumar, K., Rao, C. R. N. B., & Sanjana, P. H. (2019) · IP Indian Journal of Immunology and Respiratory Medicine · doi:10.18231/j.ijirm.2019.026 · Cited by 48
“This test is designed to purify, concentrate, amplify and identify targeted rpo B gene nucleic acid sequences, and give results from unprocessed samples in 2hours, with minimal hands on time [5-8].”
MethodSolomons, R. S., Visser, D. H., Friedrich, S. O., Diacon, A. H., Hoek, K. G. P., Marais, B. J., Schoeman, J. F., & van Furth, A. M. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0394 · Cited by 44
Wang, W., Takeuchi, R., Jain, S.-H., Jiang, Y.-H., Watanuki, S., Ohtaki, Y., Nakaishi, K., Watabe, S., Lu, P., & Ito, E. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103007 · Cited by 50
“tuberculosis in suspensions containing as few as 10 1000 CFU/mL, making this technology highly sensitive [9,10].”
BackgroundDiagnosis and therapy of tuberculous meningitis in children
Principi, N., & Esposito, S. (2012) · Tuberculosis · doi:10.1016/j.tube.2012.05.011 · Cited by 46
Shenai, S., Ronacher, K., Malherbe, S., Stanley, K., Kriel, M., Winter, J. A., Peppard, T., Barry, C. E., Wang, J., Dodd, L. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160062 · Cited by 53
Self-citationA streamlined CRISPR-based test for tuberculosis detection directly from sputum
Dunkley, O. R. S., Bell, A. G., Modi, N. H., Huang, Y., Tseng, S., Reiss, R., Daivaa, N., Davis, J. L., Vargas, D. A., Banada, P. P., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx2067 · Cited by 50
Self-citationUllah, I., Javaid, A., Masud, H., Ali, M., Basit, A., Ahmad, W., Younis, F., Yasmin, R., Khan, A., Jabbar, A., et al. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000449 · Cited by 41
“Two millilitres of inactivated specimen was transferred to the Xpert test cartridge and tested according to the manufacturer’s guide [5, 7].”
BackgroundMethodInfluentialCarriquiry, G., Otero, L., González-Lagos, E., Zamudio, C., Sánchez, E., Nabeta, P., Campos, M. A. L., Echevarria, J. I., Seas, C., & Gotuzzo, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044626 · Cited by 51
Luo, T., Jiang, L., Sun, W., Fu, G., Mei, J., & Gao, Q. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02046-10 · Cited by 44
“Among these methods, real-time PCR has been one 33 of the most widely applied due to its rapidity, high sensitivity, reproducibility, and low 34 risk of contamination (7, 10, 12, 14, 18, 31).”
BackgroundMethodInfluentialAntonenka, U., Hofmann-Thiel, S., Turaev, L., Esenalieva, A., Abdulloeva, M., Sahalchyk, E., Alnour, T. M. S., & Hoffmann, H. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-280 · Cited by 44
“shown in analytical studies on Xpert MTB/RIF [2].”
BackgroundMethodEvangelopoulos, D., Prosser, G. A., Rodgers, A., Dagg, B. M., Khatri, B. L., Ho, M. M., Gutierrez, M. G., Cortes, T., & de Carvalho, L. P. S. (2019) · Nature Communications · doi:10.1038/s41467-019-12074-z · Cited by 44
Aricha, S. A., Kingwara, L., Mwirigi, N., Chaba, L., Kiptai, T., Wahogo, J., Otwabe, J. S., Onyango, P. O., Karanja, M., Ayieko, C., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4470-9 · Cited by 48
Diagnosis of opportunistic infections: HIV co-infections – tuberculosis
Scott, L. E., Silva, P. F., Boehme, C. C., Stevens, W. S., & Gilpin, C. M. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000345 · Cited by 51
Self-citationVincent, V., Rigouts, L., Nduwamahoro, E., Holmes, B., Cunningham, J. A., Guillerm, M., Nathanson, C.-M., Moussy, F., de Jong, B. C., Portaels, F., et al. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0223 · Cited by 43
Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance
Alcaide, F., & Coll, P. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(11)70016-7 · Cited by 48
Diagnostic accuracy of xpert test in tuberculosis detection: A systematic review and meta-analysis
Dang, A., Kaur, R., Kachroo, K., Sharma, J. K., & Vatturi, S. M. (2016) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.176143 · Cited by 43
Ikuabe, P. O., & Ebuenyi, I. D. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.29.204.14579 · Cited by 43
“MDR-TB is a growing global health problem [3-6].”
BackgroundCBNAAT: A Boon for Early Diagnosis of Tuberculosis-Head and Neck
Sachdeva, K., & Shrivastava, T. (2018) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-018-1364-x · Cited by 50
Kumar, S., Gallagher, R. P., Bishop, J., Kline, E. C., Buser, J. R., Lafleur, L. K., Shah, K., Lutz, B. R., & Yager, P. (2020) · The Analyst · doi:10.1039/d0an01098g · Cited by 47
Wlodarska, M., Johnston, J. C., Gardy, J. L., & Tang, P. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00124-14 · Cited by 44
“sensitivity than the AFB smear test, being able to detect as few as 10(2) CFU/ml (1, 24, 25), though the sensitivity is lower than those”
BackgroundThe role of Xpert MTB/RIF assay in the diagnosis of tubercular spondylodiscitis
Arockiaraj, J., Michael, J. S., Amritanand, R., David, K. S., & Krishnan, V. (2017) · European Spine Journal · doi:10.1007/s00586-017-5076-9 · Cited by 42
Ng, B. Y. C., Wee, E. J. H., West, N. P., & Trau, M. (2015) · Scientific Reports · doi:10.1038/srep15027 · Cited by 43
Molecular Approaches for Detection of the Multi-Drug Resistant Tuberculosis (MDR-TB) in Bangladesh
Aurin, T. H., Munshi, S. K., Kamal, S. M. M., Rahman, M. M., Hossain, M. S., Marma, T., Rahman, F., & Noor, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099810 · Cited by 45
“The LPA method takes not more than two days for the final interpretation of results starting from specimen selection, while GeneXpert can deliver results in less than two hours [18], [24], [45].”
BackgroundMethodResultFriedrich, S. O., Venter, A., Kayigire, X. A., Dawson, R., Donald, P. R., & Diacon, A. H. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00138-11 · Cited by 40
“Another example is the Xpert MTB/RIF assay (Xpert; Cepheid; Sunnyvale, CA), employing a fully automated real-time PCR mixture contained in a disposable cartridge (13).”
MethodTarget Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers
Denkinger, C. M., Dolinger, D. L., Schito, M. L., Wells, W. A., Cobelens, F. G. J., Pai, M., Zignol, M., Cirillo, D. M., Alland, D., Casenghi, M., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu682 · Cited by 41
Self-citationŽmak, L., Makek, M. J., & Janković, V. K. (2013) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2013.05.003 · Cited by 41
Shah, M., Dowdy, D. W., Joloba, M. L., Ssengooba, W., Manabe, Y. C., Ellner, J. J., & Dorman, S. E. (2013) · AIDS · doi:10.1097/qad.0000000000000008 · Cited by 44
“However, sputum Xpert testing has limitations in sensitivity when used in people living with HIV [4–7].”
MethodPandey, S. K., Congdon, J., McInnes, B., Pop, A., & Coulter, C. (2016) · Pathology · doi:10.1016/j.pathol.2016.10.004 · Cited by 41
Lusiba, J. K., Nakiyingi, L., Kirenga, B. J., Kiragga, A., Lukande, R., Nsereko, M., Ssengooba, W., Katamba, A., Worodria, W., Joloba, M. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102702 · Cited by 39
“Xpert MTB/ RIF test (GeneXpert) is an integrated fully automated specimen processing real-time nucleic-acid-amplification test that detects MTB and rifampicin resistance within 2 hours [19–22].”
MethodKayigire, X. A., Friedrich, S. O., Venter, A., Dawson, R., Gillespie, S. H., Boeree, M. J., Heinrich, N., Höelscher, M., & Diacon, A. H. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03290-12 · Cited by 46
“Xpert is rapid (less than 1 h of hands-on time), standardized, and easy to use (6, 7).”
BackgroundKolia-Diafouka, P., Carrère‐Kremer, S., Lounnas, M., BOURDIN, A. A., Kremer, L., de Perre, P. V., Godreuil, S., & Tuaillon, É. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.02.008 · Cited by 42
Susilawati, T. N., & Larasati, R. (2019) · Medical Journal of Indonesia · doi:10.13181/mji.v28i3.2589 · Cited by 40
Pérez-Osorio, A. C., Boyle, D. S., Ingham, Z. K., Ostash, A., Gautom, R., Colombel, C., Houze, Y. B., & Leader, B. T. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05570-11 · Cited by 43
“Molecular assays that use genetic markers such as insertion sequence 6110 (IS6110) allow the sensitive and specific detection of MTBC (16, 18) and can often provide results within a day.”
MethodAranha, A., Choudhary, A., Bhaskar, S., & Gupta, L. (2018) · Asian Journal of Neurosurgery · doi:10.4103/ajns.ajns_107_18 · Cited by 39
“Of the 12 cases with definite TBM according to the TBM standard case definition (2010), [4] 11 patients showed CSF GeneXpert [4,11] positive, all showing sensitivity to rifampicin with one patient showing histopathological evidence of TB on endoscopic biopsy [Table 3].”
MethodSinha, P., Srivastava, G. N., Tripathi, R., Mishra, M. N., & Anupurba, S. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01967-5 · Cited by 40
Khan, A. S., Ali, S., Khan, M. T., Ahmed, S., Khattak, Y., Abduljabbar, Irfan, M., & Sajjad, W. (2018) · Brazilian Journal of Microbiology · doi:10.1016/j.bjm.2018.02.011 · Cited by 39
Liu, A., Nicol, E. D., Hu, Y., & Coates, A. R. M. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.08.009 · Cited by 44
Guenaoui, K., Harir, N., Ouardi, A., Zeggai, S., Sellam, F., Bekri, F., & Touil, S. C. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.05.09 · Cited by 38
“RIF resistance was excluded in 55/55 susceptible cases—100% specificity (14).”
BackgroundLuo, R. F., Scahill, M. D., & Banaei, N. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02449-09 · Cited by 38
“tuberculosis in culture and sputum (4, 6, 9, 10).”
BackgroundIruedo, J., O’Mahony, D., Mabunda, S. A., Wright, G., & Cawe, B. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2200-8 · Cited by 38
“While Xpert identifies RIF monoresistance, it is a proxy for MDR-TB [3, 4] and patients are treated as such [5].”
BackgroundBårnes, G. K., Gudina, E. K., Berhane, M., Abdissa, A., Tesfaw, G., Abebe, G., Feruglio, S. L., Caugant, D. A., & Jørgensen, H. J. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3589-4 · Cited by 37
Pinyopornpanish, K., Chaiwarith, R., Pantip, C., Keawvichit, R., Wongworapat, K., Khamnoi, P., Supparatpinyo, K., & Sirisanthana, T. (2015) · Tuberculosis Research and Treatment · doi:10.1155/2015/571782 · Cited by 54
Tenover, F. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir049 · Cited by 36
Jain, P., Thaler, D. S., Maïga, M., Timmins, G. S., Bishai, W. R., Hatfull, G. F., Larsen, M. H., & Jacobs, W. R. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir454 · Cited by 36
“Genotypic assays, commonly known as nucleic acid amplification tests (NAAT), are polymerase chain reaction (PCR)-based and rely on the identification of defined gene mutations conferring antibiotic resistance [12].”
Multiplex detection of extensively drug resistant tuberculosis using binary deoxyribozyme sensors
Bengtson, H. N., Homolka, S., Niemann, S., Reis, A. J., Silva, P. E., Gerasimova, Y. V., Kolpashchikov, D. M., & Rohde, K. H. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.02.051 · Cited by 36
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript higher than the GeneXpert MTB/RIF assay (Helb et al. 2010).”
BackgroundMethodEvaluation of GeneXpert MTB/RIF for detecting Mycobacterium tuberculosis in a hospital in China
Tang, T., Liu, F., Lü, X., & Huang, Q. (2017) · Journal of International Medical Research · doi:10.1177/0300060517698618 · Cited by 36
“tb and rapid detection of rifampicin (RIF) resistance in sputum samples.(5,6) This study aimed to evaluate the performance of the GeneXpert MTB/RIF system in diagnosing TB in a hospital in China.”
MethodPang, Y., Lu, J. L., Su, B., Zheng, H., & Zhao, Y. (2017) · Infection · doi:10.1007/s15010-017-1044-x · Cited by 36
Developments in the Diagnostic Techniques of Infectious Diseases: Rural and Urban Prospective
Srivastava, S., Singh, P. K., Vatsalya, V., & Karch, R. C. (2018) · Advances in Infectious Diseases · doi:10.4236/aid.2018.83012 · Cited by 42
“Clinical validation of the Xpert MTB/RIF technique suggested 100% specificity for smear positive culture positive as well culture negative cases [31].”
de Vos, M., Scott, L. E., David, A., Trollip, A., Hoffmann, H., Georghiou, S. B., Carmona, S., Rühwald, M., Stevens, W. S., Denkinger, C. M., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02168-20 · Cited by 37
“If we were to adjust our LOD estimates for this difference, our results largely are consistent with what has previously been reported for Xpert MTB/RIF (23, 25).”
ResultAbebe, G., Paasch, F., Apers, L., Rigouts, L., & Colebunders, R. (2010) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2010.11.014 · Cited by 42
Agizew, T., Basotli, J., Alexander, H. L., Boyd, R., Letsibogo, G., Auld, A. F., Gwebe-Nyirenda, S., Tedla, Z., Mathoma, A., Mathebula, U., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189981 · Cited by 36
Biadglegne, F., Mulu, A., Rodloff, A. C., & Sack, U. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.05.002 · Cited by 35
Molecular Detection of Resistance Determinants
Ledeboer, N. A., & Hodinka, R. L. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00771-11 · Cited by 35
“(12) and tests for rifampin resistance in Mycobacterium tuberculosis (2, 4).”
BackgroundTadesse, M., Abebe, G., Bekele, A., Bezabih, M., de Rijk, P., Meehan, C. J., de Jong, B. C., & Rigouts, L. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.09.016 · Cited by 35
Esmail, A., Tomasicchio, M., Meldau, R., Makambwa, E., & Dheda, K. U. J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.025 · Cited by 37
“The Xpert MTB/RIF and Xpert Ultra assays were performed as described previously (Helb et al., 2010).”
MethodHofmann-Thiel, S., & Hoffmann, H. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-59 · Cited by 35
“Due to the fully integrated cartridge design, the simple and safe workflow, and the ability to simultaneously detect MTBC and rifampicin (RMP) resistance, Xpert MTB/RIF allows rapid TB diagnosis and drug resistance testing also at the peripheral health clinic level [1,2].”
MethodGomgnimbou, M. K., Abadía, E., Zhang, J., Refrégier, G., Panaiotov, S., Bachiyska, E., & Sola, C. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00976-12 · Cited by 35
“TB (Innogenetics, Ghent, Belgium), GenoType MTBDRplus (Hain Life Science GmbH, Nehren, Germany) (19, 20), and the new molecular beacon test GeneXpert MTB/Rif (Cepheid, Sunnyvale, CA); these tests allow direct rifampin resistance identification in sputum (4, 17).”
BackgroundNew diagnostics for tuberculosis: fulfilling patient needs first
Lemaire, J., & Casenghi, M. (2010) · Journal of the International AIDS Society · doi:10.1186/1758-2652-13-40 · Cited by 37
“Of particular interest for implementation in resourcelimited settings are line probe assays, the implementation of which was recommended by WHO in 2008 [11], and the recently marketed Xpert MTB/RIF [ 12 ].”
BackgroundDevelopment of New Therapeutics to Meet the Current Challenge of Drug Resistant Tuberculosis
Sheikh, B. A., Bhat, B. A., Mehraj, U., Mir, W. R., Hamadani, S., & Mir, M. A. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200628021702 · Cited by 38
Potential impact of rapid diagnostic tests on improving antimicrobial use
Tenover, F. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05827.x · Cited by 34
Arnold, A., Witney, A. A., Vergnano, S., Roche, A., Cosgrove, C. A., Houston, A., Gould, K. A., Hinds, J., Riley, P. A., Macallan, D. C., et al. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.04.037 · Cited by 34
Liu, H.-C., Gao, Y.-L., Li, D., Zhao, X., Pan, Y., & Zhu, C. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02170-20 · Cited by 35
“7%) smear-negative culture-positive cases, as determined by growth on solid medium or on both solid and liquid media, respectively (6).”
BackgroundRapid Diagnosis of Mycobacterium tuberculosis Infection and Drug Susceptibility Testing
Wilson, M. L. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0578-ra · Cited by 34
13[C]-Urea Breath Test as a Novel Point-of-Care Biomarker for Tuberculosis Treatment and Diagnosis
Jassal, M. S., Nedeltchev, G. G., Lee, J., Choi, S. W., Atudorei, V. N., Sharp, Z. D., Deretic, V. P., Timmins, G. S., & Bishai, W. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012451 · Cited by 33
“tuberculosis would allow for a rapid acknowledgement of treatment efficacy and need for treatment modifications for drugresistant TB [28,29].”
BackgroundRapid Detection of rpoB Gene Mutations Conferring Rifampin Resistance in Mycobacterium tuberculosis
Ao, W., Aldous, S., Woodruff, E., Hicke, B. J., Rea, L., Kreiswirth, B. N., & JENISON, R. D. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00208-12 · Cited by 33
“Unlike other recently described molecular 286 diagnostic methods such as real-time PCR (13) and LAMP (17) with limited multiplex detection 287 capabilities, more information can be added to the TB ID/R assay to detect additional MTB resistance 288 mechanisms, potentially aiding in appropriate management and treatment…”
BackgroundMethodInfluentialUsing giant African pouched rats to detect tuberculosis in human sputum samples: 2010 findings
Mahoney, A. C., Weetjens, B. J. C., Cox, C., Beyene, N. W., Mgode, G. F., Jubitana, M., Kuipers, D., Kazwala, R. R., Mfinanga, G., Durgin, A., et al. (2011) · Pan African Medical Journal · doi:10.4314/pamj.v9i1.71204 · Cited by 33
“tuberculosis through polymerase chain reaction analysis, provides a rapid and accurate method for detecting TB in sputum [8] and APOPO is beginning research in which rat-positive, microscopy-negative samples are analyzed with the GeneExpert, which is currently too costly to use for examining all samples.”
Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
Zong, K., Chen, L., Zhou, H., Jiang, Y., & Li, S. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1516-5 · Cited by 35
Current tuberculosis diagnostic tools & role of urease breath test.
Maïga, M., Abaza, A., & Bishai, W. R. (2012) · PubMed Central · Cited by 32
Akanbi, M. O., Achenbach, C. J., Taiwo, B., Idoko, J. A., Ani, A., Isa, Y., Agbaji, O. O., Ukoli, C. O., Akande, P. A., Maïga, M., et al. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0430-6 · Cited by 32
Scott, L. E., Gous, N. M., Cunningham, B., Kana, B. D., Perovic, O., Erasmus, L., Coetzee, G. J., KOORNHOF, H. J., & Stevens, W. S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05167-11 · Cited by 35
“Criteria for a verification (“fit for purpose”) and EQA program suited to the characteristics of the Xpert MTB/RIF assay (3, 8) will require the following elements.”
MethodReed, J. L., Walker, Z. J., Basu, D., Allen, V., Nicol, M. P., Kelso, D. M., & McFall, S. M. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.09.002 · Cited by 34
Scott, L. E., David, A., Noble, L. D., Nduna, M., Silva, P. D., Black, A. D., Venter, F., & Stevens, W. S. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00289-17 · Cited by 32
“The qualitative performance of the Xpert MTB/RIF assay has been extensively described elsewhere (26, 27).”
MethodIgarashi, Y., Chikamatsu, K., Aono, A., Yi, L., Yamada, H., Takaki, A., & Mitarai, S. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.08.016 · Cited by 32
Huo, F., Ma, Y., Liu, R., Ma, L., Li, S., Jiang, G., Wang, F., Shang, Y., Dong, L., & Pang, Y. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa279 · Cited by 32
Massire, C., Ivy, C. A., Lovari, R., Kurepina, N. E., Li, H., Blyn, L. B., Hofstadler, S. A., Khechinashvili, G., Stratton, C. W., Sampath, R., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01578-10 · Cited by 31
“Recent work (16) has demonstrated that the characterization of resistance mutations directly from sputum samples is achievable, and validation of the PCR/ ESI-MS assay using direct sputum specimens is planned.”
BackgroundDetection of Mycobacterium tuberculosis in Blood by Use of the Xpert MTB/RIF Assay
Banada, P. P., Koshy, R., & Alland, D. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00332-13 · Cited by 31
“tuberculosis and rifampin resistance (29).”
Self-citationYezli, S., Zumla, A. I., Yassin, Y. M., Al-Shangiti, A. M., Mohamed, G., Turkistani, A. M., & Alotaibi, B. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.17-0271 · Cited by 31
“All sputum samples were processed after Hajj at the Saudi National TB Laboratory (Riyadh, KSA) using the WHO-endorsed Xpert MTB/RIF assay for the rapid diagnosis of TB and MDR-TB as described previously.(6) * Address correspondence toBadriahAlotaibi, Global Centre forMass Gatherings Medicine (GCMGM), Ministry of Healt…”
MethodSarro, Y. D. S., Kone, B., Diarra, B., Kumar, A., Kodio, O., Fofana, D., Achenbach, C. J., Béavogui, A. H., Seydi, M., Holl, J. L., et al. (2018) · Clinical Microbiology and Infectious Diseases · doi:10.15761/cmid.1000144 · Cited by 31
“A negative Xpert result needs to repeat and confirmed by sputum culture which increases the cost [34,35].”
BackgroundScott, L. E., Albert, H., Gilpin, C., Alexander, H. L., DeGruy, K., & Stevens, W. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03533-13 · Cited by 33
“This is further explained by the assay’s molecular characteristics; Xpert is an automated molecular technology that amplifies the rpoB gene of Mycobacterium tuberculosis and detects this target using molecular beacons (7, 8).”
BackgroundMethodLes nouveaux outils de diagnostic microbiologique de la tuberculose maladie
Guillet-Caruba, C., Pourcher, V., & Doucet‐Populaire, F. (2014) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2014.05.001 · Cited by 31
Challenges in diagnosing tuberculosis in children: a comparative study from Sudan
Elhassan, M. M., Elmekki, M. A., Osman, A. L., & Hamid, M. E. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.12.006 · Cited by 34
“tuberculosis directly from sputum, thereby allowing an earlier start of therapy.(24) Detjen et al.”
BackgroundPrinciples of Anti-Infective Therapy
Eliopoulos, G. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00287-6 · Cited by 31
Kolia-Diafouka, P., Godreuil, S., BOURDIN, A. A., Carrère‐Kremer, S., Kremer, L., de Perre, P. V., & Tuaillon, É. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02224 · Cited by 35
Denkinger, C. M., Kik, S. V., & Pai, M. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.850034 · Cited by 33
O’Sullivan, D. M., Nicoarã, S., Mutetwa, R., Mungofa, S., Lee, O. Y.-C., Minnikin, D. E., Bardwell, M. W., Corbett, E. L., McNerney, R., & Morgan, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032836 · Cited by 30
The future of molecular diagnostics for drug-resistant tuberculosis
Heysell, S. K., & Houpt, E. R. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.25 · Cited by 30
Kaswa, M. K., Hasker, E. C., Aloni, M., Nkuku, L., Kazadi, M., Kabengele, T., Muteteke, D., Kapita, F., Lufulwabo, A., Mukadi, Y. D., et al. (2018) · Emerging infectious diseases · doi:10.3201/eid2411.180769 · Cited by 30
“cessed in Xpert according to standard methods (12,16).”
MethodDastgir, G., Majeed, M. I., Nawaz, H., Rashid, N., Raza, A., Ali, M., Shakeel, M., Javed, M., Ehsan, U., Ishtiaq, S., et al. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2022.102758 · Cited by 30
Xpert MTB/RIF: monitoring response to tuberculosis treatment
Nicol, M. P. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70133-4 · Cited by 30
Zhang, Q., Zhang, Q., Sun, B., Liu, C., Su, A., Wang, X., Liu, N., Zhang, J., Kang, J., & Hou, G. (2018) · Respirology · doi:10.1111/resp.13316 · Cited by 30
Increasing access to diagnostics through technology transfer and local production
Peeling, R. W. W., & McNerney, R. (2011) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · Cited by 37
Ou, X., Song, Y., Zhao, B., Li, Q., Xia, H., Zhou, Y., Pang, Y., Wang, S., Zhang, Z., Cheng, S., et al. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.04.006 · Cited by 29
Rapid Diagnosis of Pediatric Mycobacterial Lymphadenitis Using Fine Needle Aspiration Biopsy
Coetzee, L., Nicol, M. P., Jacobson, R., Schubert, P. T., van Helden, P. D., Warren, R. M., & Wright, C. A. (2014) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000312 · Cited by 29
McCarthy, K., Grant, A. D., Chihota, V. N., Ginindza, S., Mvusi, L., Churchyard, G., & Fielding, K. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000907 · Cited by 29
“10–80 505 (45) 21 (9) 434 (42) 44 (15)”
Kamolwat, P., Nateniyom, S., Chaiprasert, A., Disratthakit, A., Mahasirimongkol, S., Yamada, N., & Smithtikarn, S. (2020) · Tropical Medicine & International Health · doi:10.1111/tmi.13502 · Cited by 29
“The GeneXpert MTB/RIF assay was performed as described previously [11, 12].”
MethodByanyima, P., Kaswabuli, S., Musisi, E., Nabakiibi, C., Zawedde, J., Sanyu, I., SESSOLO, A., Andama, A. O., Worodria, W. O., Huang, L., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00860-22 · Cited by 33
Blazing the trail for innovative tuberculosis diagnostics
Yerlikaya, S., Broger, T., Isaacs, C., Bell, D., Holtgrewe, L., Gupta‐Wright, A., Nahid, P., Cattamanchi, A., & Denkinger, C. M. (2023) · Infection · doi:10.1007/s15010-023-02135-3 · Cited by 30
“Since its introduction in 2010, the GeneXpert Dx System (Cepheid, CA, USA), an integrated, single-use cartridge-based diagnostic system, has been the molecular diagnostic test of preference for TB [117].”
BackgroundMethod
Metadata
- Authors
- Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., Safi, H., Blakemore, R., Lan, N. T. N., Jones-López, E. C., Levi, M., Burday, M., Ayakaka, I., Mugerwa, R. D., McMillan, B., Winn-Deen, E., Christel, L., Dailey, P., Perkins, M. D., Persing, D. H., & Alland, D.
- Affiliations
- Rutgers New Jersey Medical School (US)
- Cepheid (United States) (US)
- Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry, New Jersey, Newark, New Jersey
- FIND (CH)
- Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
- Montefiore Medical Center (US)
- Makerere University (UG)
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 48
- Issue
- 1
- Pages
- 229-237
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC2812290
- OpenAlex
- W2112022845
- Cited by
- 914
- References
- 59
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 35 · 2023: 33 · 2022: 36 · 2021: 45 · 2020: 65 · 2019: 55 · 2018: 61 · 2017: 62 · 2016: 63 · 2015: 62 · 2014: 74 · 2013: 71 · 2012: 62
- FWCI
- 41.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R41AI052523, R42AI052523, R42-AI52523, R41-AI52523)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- Mycobacterium tuberculosis detection, rifampicin resistance, Xpert MTB/RIF, point-of-care testing, real-time PCR, sputum, detection limit, nontuberculous mycobacteria, retreatment tuberculosis, tuberculosis diagnosis
- MeSH terms
- Adolescent, Adult, Aged, Antitubercular Agents, Bacteriological Techniques, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis, Rifampin, Sensitivity and Specificity, Sputum, Tuberculosis, Uganda, Vietnam, Polymerase Chain Reaction, Point-of-Care Systems, Drug Resistance, Bacterial, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.